Theseus Pharmaceuticals Statistics
Total Valuation
KMRK has a market cap or net worth of $25.53 million. The enterprise value is $21.27 million.
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
KMRK has 21.10 million shares outstanding.
Current Share Class | 16.60M |
Shares Outstanding | 21.10M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 78.20% |
Owned by Institutions (%) | n/a |
Float | 4.60M |
Valuation Ratios
The trailing PE ratio is 25.79.
PE Ratio | 25.79 |
Forward PE | n/a |
PS Ratio | 1.22 |
Forward PS | n/a |
PB Ratio | 8.18 |
P/TBV Ratio | 8.85 |
P/FCF Ratio | 12.63 |
P/OCF Ratio | 12.63 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
The stock's EV/EBITDA ratio is 20.66, with an EV/FCF ratio of 10.52.
EV / Earnings | 23.28 |
EV / Sales | 1.10 |
EV / EBITDA | 20.66 |
EV / EBIT | 23.29 |
EV / FCF | 10.52 |
Financial Position
The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.48.
Current Ratio | 1.61 |
Quick Ratio | 1.58 |
Debt / Equity | 0.48 |
Debt / EBITDA | 1.33 |
Debt / FCF | 0.68 |
Interest Coverage | 12.20 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 23.01% |
Revenue Per Employee | $966,091 |
Profits Per Employee | $45,671 |
Employee Count | 20 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
In the past 12 months, KMRK has paid $134,151 in taxes.
Income Tax | 134,151 |
Effective Tax Rate | 12.81% |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | n/a |
Average Volume (20 Days) | 1,514,921 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KMRK had revenue of $19.32 million and earned $913,422 in profits. Earnings per share was $0.05.
Revenue | 19.32M |
Gross Profit | 2.58M |
Operating Income | 913,287 |
Pretax Income | 1.05M |
Net Income | 913,422 |
EBITDA | 1.03M |
EBIT | 913,287 |
Earnings Per Share (EPS) | $0.05 |
Full Income Statement Balance Sheet
The company has $5.64 million in cash and $1.37 million in debt, giving a net cash position of $4.26 million or $0.20 per share.
Cash & Cash Equivalents | 5.64M |
Total Debt | 1.37M |
Net Cash | 4.26M |
Net Cash Per Share | $0.20 |
Equity (Book Value) | 2.88M |
Book Value Per Share | 0.15 |
Working Capital | 3.40M |
Full Balance Sheet Cash Flow
Operating Cash Flow | 2.02M |
Capital Expenditures | n/a |
Free Cash Flow | 2.02M |
FCF Per Share | $0.10 |
Full Cash Flow Statement Margins
Gross margin is 13.33%, with operating and profit margins of 4.73% and 4.73%.
Gross Margin | 13.33% |
Operating Margin | 4.73% |
Pretax Margin | 5.42% |
Profit Margin | 4.73% |
EBITDA Margin | 5.33% |
EBIT Margin | 4.73% |
FCF Margin | 10.46% |
Dividends & Yields
KMRK does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 3.58% |
FCF Yield | 7.92% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | |
Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
KMRK has an Altman Z-Score of 3.18 and a Piotroski F-Score of 3.
Altman Z-Score | 3.18 |
Piotroski F-Score | 3 |